Trademark Overview
On Tuesday, November 12, 2024, a trademark application was filed for ROZELCRA with the United States Patent and Trademark Office. The USPTO has given the ROZELCRA trademark a serial number of 98848260. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, July 3, 2025. This trademark is owned by PRG S&Tech Inc.. The ROZELCRA trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) patients for medical purposes; pharmaceutical products for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS); medicinal preparations for symptom improvement and treatment of Hutchinson-Gilford Progeria Syndrome (HGPS) for human purposes; pharmaceutical products for the treatment of progeria; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations acting on the central nervous system for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS)
